title: [Tuberculosis annual report 2010--(9) Treatment of tuberculosis-2].
abstract: The standard treatment for tuberculosis (TB) is the key to its control. Here we report statistics relating to treatment status and the duration of hospitalization and treatment in Japan. Among the newly noted TB patients in 2010, sputum-smear positive pulmonary TB patients were the most likely to receive hospital treatment (91.4%); 2.5% of these patients were primarily hospitalized for other diseases. The median duration of hospitalization in newly notified TB cases in 2009 was 73 days for new sputum-smear positive pulmonary TB cases, 75 days for sputum-smear positive pulmonary TB cases undergoing further treatment, 42 days for other bacillary positive pulmonary TB cases, 40.5 days for bacillary negative pulmonary TB cases, and 44 days for extra-pulmonary TB cases. The duration of TB treatment among newly notified cases in 2009 was assessed at the end of 2010. The median treatment duration for all forms of TB was 270 days. The longest median treatment duration was 285 days for retreatment of sputum-smear positive pulmonary TB cases, and the shortest duration was 196 days for bacillary-negative pulmonary TB cases.
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000995:Antitubercular Agents / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007223:Infant; D007538:Isoniazid / Q000008:administration & dosage; D007564:Japan / Q000453:epidemiology; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D012042:Registries / Q000706:statistics & numerical data*; D012293:Rifampin / Q000008:administration & dosage; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology*; D055815:Young Adult
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin